| Income Statement |
| Operating Expenses | 2.22M |
|
| Research and Development Expense | 1.08M |
| Selling, General and Administrative Expense | 1.16M |
| Operating Income | -2.22M |
| Income Tax Expense | 192.00K |
| Net Income | -2.16M |
| Net Income Common Stock | -2.16M |
| Net Income Common Stock (USD) | -2.16M |
| Consolidated Income | -6.67M |
| Net Income from Discontinued Operations | 4.32M |
| Net Income to Non-Controlling Interests | -4.51M |
| Earnings per Basic Share | -0.05 |
| Earnings per Basic Share (USD) | -0.05 |
| Earnings per Diluted Share | -0.05 |
| Earning Before Interest & Taxes (EBIT) | -1.97M |
| Earning Before Interest & Taxes (USD) | -1.97M |
| Weighted Average Shares | 41.12M |
| Weighted Average Shares Diluted | 41.12M |
| Balance Sheet |
| Cash and Equivalents | 4.04M |
| Cash and Equivalents (USD) | 4.04M |
| Investments | 3.83M |
| Investments Current | 3.83M |
| Trade and Non-Trade Receivables | 177.00K |
| Current Assets | 13.50M |
| Property, Plant & Equipment Net | 392.00K |
| Total Assets | 18.41M |
| Debt Current | 246.00K |
| Total Debt | 246.00K |
| Current Liabilities | 12.37M |
| Total Liabilities | 48.76M |
| Accumulated Retained Earnings (Deficit) | -410.59M |
| Accumulated Other Comprehensive Income | 360.00K |
| Shareholders Equity | -34.49M |
| Shareholders Equity (USD) | -34.49M |
| Assets Non-Current | 4.90M |
| Total Debt (USD) | 246.00K |
| Deferred Revenue | 28.99M |
| Liabilities Non-Current | 36.39M |
| Trade and Non-Trade Payables | 646.00K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 19.00K |
| Net Cash Flow from Financing | -4.16M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.93M |
| Issuance (Purchase) of Equity Shares | -8.00K |
| Issuance (Repayment) of Debt Securities | -4.43M |
| Net Cash Flow from Investing | 4.48M |
| Net Cash Flow - Investment Acquisitions and Disposals | 4.48M |
| Net Cash Flow from Operations | -3.28M |
| Effect of Exchange Rate Changes on Cash | 22.00K |
| Share Based Compensation | 461.00K |